News - Pharmaceutical, Asia-Pacific, Pricing

Filter

1 to 25 of 120 results

Pharmaceutical CPI growth due to Australian government policy

23-04-2014

The Australian Consumer Price Index (CPI) for the March quarter has shown growth in pharmaceutical prices…

Asia-PacificAustraliaPharmaceuticalPoliticsPricing

Vietnam's pharma market among the fastest growing in Southeast Asia

22-04-2014

Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalPricing

Price cuts mean PBS can afford new medicines, says Medicines Australia

Price cuts mean PBS can afford new medicines, says Medicines Australia

01-04-2014

As of today in Australia, price cuts come into effect for 121 medicines, and trade group Medicines Australia…

Asia-PacificAustraliaHealthcarePharmaceuticalPricing

Latest Australian PBS Listings include medicines for children

Latest Australian PBS Listings include medicines for children

19-03-2014

Ten new medicines to treat a range of illnesses from rare forms of cancer to skin conditions will be…

Anti-Arthritics/RheumaticsAsia-PacificAustraliaDermatologicalsDiabetesGastro-intestinalsHealthcareOncologyPharmaceuticalPricing

Streamlined PBS pricing processes to improve access to medicines in Australia

Streamlined PBS pricing processes to improve access to medicines in Australia

07-03-2014

From April 1, the Australian government will implement a new streamlined process to reduce the time taken…

Asia-PacificAustraliaPharmaceuticalPricingRegulation

2014 to be transition year for Japan pharma

2014 to be transition year for Japan pharma

11-02-2014

2014 will be marked as a transition year for the Japanese Pharma industry – but the year is bound to…

Asia-PacificPharmaceuticalPricingRegulationResearch

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India

03-02-2014

Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…

Asia-PacificAstraZenecaFinancialGlaxoSmithKlineIndiaNovartisPfizerPharmaceuticalPricing

Report: India’s strong commercial opportunities hampered by bureaucracy and poor policy planning

Report: India’s strong commercial opportunities hampered by bureaucracy and poor policy planning

09-01-2014

Due to its large population and substantial unmet medical needs, India represents a market with strong…

Asia-PacificIndiaMarkets & MarketingPharmaceuticalPricingRegulation

Citing “unreasonable price,” New Zealand declines eculizumab funding

Citing “unreasonable price,” New Zealand declines eculizumab funding

13-12-2013

New Zealand’s Pharmaceutical Management Agency PHARMAC has declined the funding application for eculizumab…

Alexion PharmaceuticalsAsia-PacificeculizumabGlaxoSmithKlineHematologyNew ZealandPharmaceuticalPricingRare diseasesRevoladeSoliris

New agreement with GSK provides new medicines, saves millions for New Zealand

New agreement with GSK provides new medicines, saves millions for New Zealand

11-12-2013

A new agreement with the local subsidiary of UK pharma giant GlaxoSmithKline by New Zealand’s Pharmaceutical…

Anti-viralsAsia-PacificGlaxoSmithKlineHealthcareHematologyNew ZealandPharmaceuticalPricingRespiratory and PulmonarySeretideSerevent Diskus

New Zealand funding plans for Tarceva and Revolade

New Zealand funding plans for Tarceva and Revolade

09-12-2013

Following a consultation, New Zealand’s Pharmaceutical Management Agency PHARMAC said this morning…

Asia-PacificGlaxoSmithKlineHematologyNew ZealandOncologyPharmaceuticalPricingRegulationRevoladeRocheTarceva

Report 4: Growth strategies in Japan’s pharma market – Products – by P Reed Maurer

Report 4: Growth strategies in Japan’s pharma market – Products – by P Reed Maurer

05-12-2013

Japan has a long history of rewarding innovation across many industrial sectors, including the pharmaceutical…

Asia-PacificMarkets & MarketingPharmaceuticalPricing

Medicines Australia calls on government to review PBS assessment process

Medicines Australia calls on government to review PBS assessment process

02-12-2013

Trade body Medicines Australia has submitted a report to the National Commission of Audit which shows…

Asia-PacificAustraliaHealthcarePharmaceuticalPoliticsPricing

Different Rxing patterns for premium-priced therapies in China and South Korea

26-11-2013

In China, a combination of government restrictions on reimbursement and regional variations in formulary…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalPricing

Japan NHI price listing for Chugai’s Kadcyla delayed

14-11-2013

Japanese drugmaker Chugai Pharmaceutical, which is majority owned by Swiss major Roche, says that the…

Asia-PacificChugai PharmaceuticalKadcylaOncologyPharmaceuticalPricingResearchRoche

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

Japan’s drug pricing authority starts debates on institutionalization of premium system

Japan’s drug pricing authority starts debates on institutionalization of premium system

21-10-2013

It was three weeks ago when the Central Social Insurance Medical Council (CSIMC) held a meeting and listened…

Asia-PacificPharmaceuticalPoliticsPricing

Asia-Pacific solid tumors market to reach $2.3 billion by 2019

08-10-2013

The Asia-Pacific solid tumors treatment markets - bladder, ovarian, pancreatic and prostate cancers -…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalPricing

Japan’s drug pricing authority hears opinions from pharma industry

Japan’s drug pricing authority hears opinions from pharma industry

30-09-2013

Japan’s Central Social Insurance Medical Council held a meeting last week of its Drug Pricing Subcommittee…

Asia-PacificPharmaceuticalPoliticsPricing

Imported medicine pricing discrepancies in China explained

09-09-2013

Guo Jianying, a senior official with the pricing division of the National Development and Reform Commission,…

Asia-PacificPharmaceuticalPricing

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

Japan's PM supports reform of drug pricing rules

27-08-2013

The Japanese Prime Minister, Shinzo Abe, last week held a meeting of the Council for Regulatory Reform…

Asia-PacificPharmaceuticalPoliticsPricing

Support for the Australia's PBS from Coalition Senators

22-08-2013

Ahead of the September 7 elections, Australian Coalition Senators have issued a statement acknowledging…

Asia-PacificPharmaceuticalPoliticsPricingRegulation

New Zealand proposals for influenza vaccines

21-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

1 to 25 of 120 results

Back to top